Literature DB >> 17042380

In vitro heterogeneity of osteogenic cell populations at various equine skeletal sites.

Laurie A McDuffee1, Gail I Anderson, Glenda M Wright, Daniel A J Ryan.   

Abstract

Bone cell cultures were evaluated to determine if osteogenic cell populations at different skeletal sites in the horse are heterogeneous. Osteogenic cells were isolated from cortical and cancellous bone in vitro by an explant culture method. Subcultured cells were induced to differentiate into bone-forming osteoblasts. The osteoblast phenotype was confirmed by immunohistochemical testing for osteocalcin and substantiated by positive staining of cells for alkaline phosphatase and the matrix materials collagen and glycosaminoglycans. Bone nodules were stained by the von Kossa method and counted. The numbers of nodules produced from osteogenic cells harvested from different skeletal sites were compared with the use of a mixed linear model. On average, cortical bone sites yielded significantly greater numbers of nodules than did cancellous bone sites. Between cortical bone sites, there was no significant difference in nodule numbers. Among cancellous sites, the radial cancellous bone yielded significantly more nodules than did the tibial cancellous bone. Among appendicular skeletal sites, tibial metaphyseal bone yielded significantly fewer nodules than did all other long bone sites. This study detected evidence of heterogeneity of equine osteogenic cell populations at various skeletal sites. Further characterization of the dissimilarities is warranted to determine the potential role heterogeneity plays in differential rates of fracture healing between skeletal sites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17042380      PMCID: PMC1562541     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  33 in total

1.  Age-related changes in the biomolecular mechanisms of calvarial osteoblast biology affect fibroblast growth factor-2 signaling and osteogenesis.

Authors:  Catherine M Cowan; Natalina Quarto; Stephen M Warren; Ali Salim; Michael T Longaker
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

2.  Sustained in vitro expansion of bone progenitors is cell density dependent.

Authors:  Kelly A Purpura; Jane E Aubin; Peter W Zandstra
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

3.  Characterization and evaluation of asymptomatic primary hyperparathyroidism.

Authors:  J P Bilezikian; S J Silverberg; E Shane; M Parisien; D W Dempster
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

4.  Comparison of bone formed intramuscularly after transplantation of scapular and calvarial osteoblasts.

Authors:  S Moskalewski; A Osiecka; J Malejczyk
Journal:  Bone       Date:  1988       Impact factor: 4.398

5.  Osteoprogenitor viability in cell populations isolated from rat femora is not affected by 24 h storage at 4 degrees C.

Authors:  N Basso; P Mirkopoulos; J N M Heersche
Journal:  Cryobiology       Date:  2005-04       Impact factor: 2.487

6.  Insulin-like growth factor-1 and -2 stimulate osteoprogenitor proliferation and differentiation and adipocyte formation in cell populations derived from adult rat bone.

Authors:  D Jia; J N Heersche
Journal:  Bone       Date:  2000-12       Impact factor: 4.398

7.  Enhancement of human osteoblast proliferation and phenotypic expression when cultured in human serum.

Authors:  D P Hankey; R E McCabe; M J Doherty; P C Nolan; M G McAlinden; J Nelson; D J Wilson
Journal:  Acta Orthop Scand       Date:  2001-08

8.  The effects of patient age on human osteoblasts' response to Ti-6Al-4V implants in vitro.

Authors:  Hai Zhang; Courtland G Lewis; Michael S Aronow; Gloria A Gronowicz
Journal:  J Orthop Res       Date:  2004-01       Impact factor: 3.494

9.  Human bone cells in vitro.

Authors:  P G Robey; J D Termine
Journal:  Calcif Tissue Int       Date:  1985-09       Impact factor: 4.333

10.  Isolation of bone cell clones with differences in growth, hormone responses, and extracellular matrix production.

Authors:  J E Aubin; J N Heersche; M J Merrilees; J Sodek
Journal:  J Cell Biol       Date:  1982-02       Impact factor: 10.539

View more
  4 in total

1.  Equine bone marrow-derived mesenchymal stromal cells (BMDMSCs) from the ilium and sternum: are there differences?

Authors:  M K Adams; L R Goodrich; S Rao; F Olea-Popelka; N Phillips; J D Kisiday; C W McIlwraith
Journal:  Equine Vet J       Date:  2012-09-26       Impact factor: 2.888

Review 2.  Therapeutic mesenchymal stromal stem cells: Isolation, characterization and role in equine regenerative medicine and metabolic disorders.

Authors:  Mohamad Al Naem; Lynda Bourebaba; Katarzyna Kucharczyk; Michael Röcken; Krzysztof Marycz
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

Review 3.  Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine.

Authors:  Thomas G Koch; Lise C Berg; Dean H Betts
Journal:  Can Vet J       Date:  2009-02       Impact factor: 1.008

4.  Isolation and characterization of multipotent mesenchymal stromal cells from the gingiva and the periodontal ligament of the horse.

Authors:  Niels Mensing; Hagen Gasse; Nina Hambruch; Jan-Dirk Haeger; Christiane Pfarrer; Carsten Staszyk
Journal:  BMC Vet Res       Date:  2011-08-02       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.